Corporate News     08-Apr-22
Gufic BioSciences receives ratings action from CRISIL
Gufic BioSciences announced that CRISIL has reaffirmed the long term rating of CRISIL BBB+/ Positive and assigned the short term rating of CRISIL A2 for the bank facilities (Rs 145 crore) availed by the company.
Previous News
  Gufic BioSciences standalone net profit rises 158.95% in the March 2021 quarter
 ( Results - Announcements 05-Jun-21   07:42 )
  Gufic BioSciences standalone net profit rises 11.33% in the September 2018 quarter
 ( Results - Announcements 15-Nov-18   13:47 )
  Gufic BioSciences standalone net profit declines 3.28% in the December 2022 quarter
 ( Results - Announcements 11-Feb-23   07:36 )
  Gufic BioSciences announces board meeting date
 ( Corporate News - 11-Nov-19   10:42 )
  Board of Gufic BioSciences recommends final dividend
 ( Corporate News - 22-Aug-19   12:06 )
  Gufic BioSciences standalone net profit declines 12.61% in the June 2015 quarter
 ( Results - Announcements 15-Aug-15   15:13 )
  Gufic BioSciences to declare Quarterly Result
 ( Corporate News - 08-Feb-24   19:14 )
  Board of Gufic BioSciences recommends final dividend
 ( Corporate News - 05-Jun-21   10:29 )
  Gufic BioSciences standalone net profit rises 86.58% in the December 2017 quarter
 ( Results - Announcements 13-Feb-18   17:48 )
  Gufic BioSciences standalone net profit rises 87.75% in the December 2020 quarter
 ( Results - Announcements 09-Feb-21   08:54 )
  Gufic BioSciences to hold board meeting
 ( Corporate News - 12-Aug-15   10:06 )
Other Stories
  Mahindra Lifespace Developers acquires 2.37 land for development in South Bengaluru
  04-Jul-24   18:27
  Mahindra Lifespace Developers to undertake redevelopment project in Borivali, Mumbai
  04-Jul-24   18:25
  Ahluwalia Contracts wins order of Rs 572 cr
  04-Jul-24   18:13
  Dilip Buildcon divest 51% stake in project SPV (Pathrapali Kathgora Highways)
  04-Jul-24   18:06
  NBCC (India) wins work order from National Institute of Technology
  04-Jul-24   16:15
  CAMS appoints director
  04-Jul-24   16:13
  Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
  04-Jul-24   16:11
  Board of Lloyds Metals & Energy approves allotment of convertible warrants aggregating Rs 2960 cr
  04-Jul-24   16:07
  Oil India allots 54.22 crore equity shares under bonus issue
  04-Jul-24   15:41
  Ishaan Infrastructure & Shelters cancels board meeting
  04-Jul-24   15:26
Back Top